|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
08.07.26 - 18:03
|
SpineGuard Announces its H1 2026 Revenue (Business Wire)
|
|
|
PARIS & BOULDER, Colo.--(BUSINESS WIRE)--Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced its first half 2026 revenue.
Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated:
“Revenue for the first half of the year is in line with our roadmap. Our DSG technology is increasingly establishing itself as the efficient and reliable alternative to navigation systems and robots, whose cost and associated constraints limit their adoption by practitioners and hospitals.
In the United States, the transitional effects related to the sale of SpineGuard Inc. and the shift to a distribution model were anticipated. These effects are accompanied by an improvement in our profitability per unit sold and should enable a gradual ramp-up in sales volumes of Pediguard devices thanks to commercial synergies with Omnia Medical. Pr...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|